Dashboard
Financial statements
DXCM

Company financials

Dexcom

Health Care Health Care Equipment San Diego, California Last filing Feb 12, 2026 · FY2025
Revenue FY2025
$4.7B
3y CAGR +17.0% P95
Net income FY2025
$836.3M
Net margin +17.9% P73
Total assets FY2025
$6.3B
ROA +13.2% P82
Operating cash flow FY2025
$1.4B
FCF margin +23.1% P84
17 yrs · FY2009–FY2025 9 filed · 0 derived · 0 blank

Balance Sheet

Assets, liabilities, and equity

32 accounts · 10 years
Total assets $6.3B
Total liabilities $3.6B
Shareholders equity $2.7B
Account 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Trend
Assets
Cash and Cash Equivalents $917.7M 51.4% $606.1M 7.0% $566.3M -11.8% $642.3M -39.0% $1.1B 28.7% $817.6M 83.2% $446.2M -60.8% $1.1B 157.5% $441.5M 367.2% $94.5M
Short Term Investments $218.0M -87.4% $1.7B -19.9% $2.2B 19.3% $1.8B 33.1% $1.4B $107.1M 266.8% $29.2M
Accounts Receivable $1.2B 20.9% $1.0B 3.3% $973.9M 36.5% $713.3M 38.7% $514.3M 20.0% $428.5M 49.7% $286.3M 26.3% $226.7M 68.8% $134.3M 32.1% $101.7M
Inventory $629.1M 15.9% $542.6M -3.0% $559.6M 82.5% $306.7M -14.2% $357.3M 52.2% $234.7M 95.9% $119.8M 69.4% $70.7M 56.4% $45.2M -0.4% $45.4M
Prepaid Expenses $189.4M 9.0% $173.7M 3.2% $168.3M -12.6% $192.6M 136.0% $81.6M 51.4% $53.9M 79.7% $30.0M 81.8% $16.5M -0.6% $16.6M 80.4% $9.2M
Other Current Assets $29.2M -26.4% $39.7M -19.5% $49.3M 33.2% $37.0M
Total Current Assets $4.0B -6.2% $4.3B -2.8% $4.4B 20.6% $3.7B -0.4% $3.7B 7.6% $3.4B 73.9% $2.0B 15.9% $1.7B 128.2% $744.7M 166.0% $280.0M
Property,Plant and Equipment $1.6B 16.4% $1.3B 20.4% $1.1B 5.4% $1.1B 31.7% $801.8M 55.6% $515.3M 60.4% $321.3M 75.5% $183.1M 25.8% $145.6M 33.1% $109.4M
Operating Lease Assets $77.4M 23.2% $62.8M -12.0% $71.4M -10.8% $80.0M -9.2% $88.1M -5.6% $93.3M 30.5% $71.5M
Goodwill $24.2M 6.1% $22.8M -9.5% $25.2M -1.9% $25.7M -3.0% $26.5M 37.3% $19.3M 3.8% $18.6M -0.5% $18.7M 54.5% $12.1M 7.1% $11.3M
Intangible Assets $70.8M -31.5% $103.4M -23.1% $134.5M -22.4% $173.3M $0 $0 $0 $0 $0 $0
Long Term Investments $218.0M 82.7% $119.3M 209.9% $38.5M 102.6% $19.0M
Deferred Tax Assets $295.6M -38.6% $481.2M 14.7% $419.4M 22.9% $341.2M 54.5% $220.8M 2.0% $216.4M -38.5% $351.7M 5.3% $334.1M 19.3% $280.0M 41.6% $197.8M
Other Noncurrent Assets $278.7M 61.1% $173.0M 130.7% $75.0M 59.2% $47.1M 12.1% $42.0M 96.3% $21.4M 50.7% $14.2M -3.4% $14.7M 764.7% $1.7M -10.5% $1.9M
Total Assets $6.3B -2.2% $6.5B 3.5% $6.3B 16.2% $5.4B 10.9% $4.9B 13.4% $4.3B 79.1% $2.4B 25.0% $1.9B 111.9% $904.1M 124.5% $402.8M
Liabilities
Accounts Payable $344.3M -0.3% $345.3M 24.9% $276.4M 16.2% $237.9M 21.4% $196.0M 20.0% $163.3M 59.6% $102.3M 35.5% $75.5M 61.7% $46.7M 90.6% $24.5M
Accrued Liabilities $45.8M 23.5% $37.1M -8.4% $40.5M -18.8% $49.9M 4.2% $47.9M 9.4% $43.8M 11.2% $39.4M 131.8% $17.0M 58.9% $10.7M -46.5% $20.0M
Operating Lease Liabilities $21.6M -4.0% $22.5M 6.6% $21.1M 2.9% $20.5M 0.0% $20.5M 24.2% $16.5M 21.3% $13.6M
Other Current Liabilities $7.7M
Total Current Liabilities $2.1B -26.9% $2.9B 88.4% $1.6B -15.4% $1.8B 155.2% $720.8M 17.4% $614.1M 70.5% $360.2M 62.0% $222.4M 60.1% $138.9M 35.6% $102.4M
Long Term Debt $0 $0 $0 $0 $0 $0 $0 $0 -100.0% $8.0M $0
Operating Lease Liabilities Noncurrent $73.4M 12.9% $65.0M -18.9% $80.1M -15.3% $94.6M -4.1% $98.6M -3.1% $101.8M 40.6% $72.4M
Other Noncurrent Liabilities $137.1M -7.3% $147.9M 17.8% $125.6M -2.1% $128.3M 42.6% $90.0M 11.2% $80.9M 302.5% $20.1M 0.5% $20.0M 9.9% $18.2M 9.6% $16.6M
Total Liabilities $3.6B -18.0% $4.4B 4.4% $4.2B 28.7% $3.3B 24.8% $2.6B 6.0% $2.5B 62.9% $1.5B 20.7% $1.3B 158.4% $484.7M 307.3% $119.0M
Equity
Preferred Stock $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Common Stock $400.0K 0.0% $400.0K 0.0% $400.0K 0.0% $400.0K 300.0% $100.0K 0.0% $100.0K 0.0% $100.0K 0.0% $100.0K 0.0% $100.0K 0.0% $100.0K
Additional Paid In Capital $2.3B 9.0% $2.1B -40.4% $3.5B 55.6% $2.3B -9.8% $2.5B 17.8% $2.1B 26.8% $1.7B 7.4% $1.6B 42.7% $1.1B 20.8% $905.7M
Retained Earnings $2.4B 52.3% $1.6B 56.4% $1.0B 112.8% $479.9M 1112.4% $-47.4M 76.5% $-202.1M 71.0% $-695.7M 12.9% $-798.9M -18.9% $-671.8M -8.2% $-621.0M
Treasury Stock $2.1B 31.8% $1.6B -35.5% $2.5B 311.9% $595.0M 188.6% $206.2M 106.2% $100.0M 0.0% $100.0M 0.0% $100.0M $0 $0
Accumulated Other Comprehensive Income $115.0M 1537.5% $-8.0M 52.1% $-16.7M -44.0% $-11.6M -2420.0% $500.0K -84.4% $3.2M 39.1% $2.3M 53.3% $1.5M 157.7% $-2.6M -160.0% $-1.0M
Total Stockholders Equity $2.7B 30.6% $2.1B 1.6% $2.1B -3.0% $2.1B 4.4% $2.0B 31.6% $1.6B 75.8% $882.6M 33.1% $663.3M 58.2% $419.4M 47.8% $283.8M
Total Liabilitiesand Equity $6.3B -2.2% $6.5B 3.5% $6.3B 16.2% $5.4B 10.9% $4.9B 13.4% $4.3B 79.1% $2.4B 25.0% $1.9B 111.9% $904.1M 124.5% $402.8M

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years
Ratio 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Profitability
Gross margin +60.1% +60.5% +63.2% +64.7% +68.6% +66.4% +63.1% +64.4% +68.5% +66.0%
Operating margin +19.6% +14.9% +16.5% +13.4% +10.9% +15.5% +9.6% -18.1% -5.9% -11.1%
Net margin +17.9% +14.3% +14.9% +11.7% +8.9% +28.5% +6.8% -12.3% -7.0% -11.4%
FCF margin +23.1% +15.6% +14.1% +10.5% +2.2% +14.4% +9.1% +5.4% +3.6% +0.1%
Growth
Revenue CAGR (3y) +17.0% +18.1% +23.4% +25.4% +33.4% +38.9% +37.1% +36.9% +40.5% +53.0%
Returns
ROE +30.5% +27.4% +26.2% +16.0% +10.6% +35.4% +11.5% -19.2% -12.0% -23.1%
ROA +13.2% +8.9% +8.6% +6.3% +4.5% +12.8% +4.2% -6.6% -5.6% -16.3%
ROIC +38.3% +32.6% +30.3% +22.9% +22.7% +40.8% +31.6% +39.3% +301.4% -33.8%
Liquidity
Current ratio 1.88x 1.47x 2.84x 1.99x 5.11x 5.58x 5.47x 7.64x 5.36x 2.73x
Quick ratio 1.00x 0.55x 0.99x 0.74x 2.17x 2.03x 2.03x 6.13x 4.15x 1.92x
Leverage
D/E 1.31x 2.08x 2.03x 1.53x 1.28x 1.59x 1.71x 1.89x 1.16x 0.42x
Interest coverage 49.83x 31.58x 29.44x 21.03x 14.14x 16.92x 2.36x -8.21x -3.32x -91.29x
Efficiency
Asset turnover 0.74x 0.62x 0.58x 0.54x 0.50x 0.45x 0.62x 0.54x 0.79x 1.42x
Cash conversion cycle +151d +136d +176d +114d +153d +121d +83d +75d +66d +104d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds DXCM to your watchlist.